Detailed information for compound 214353

Basic information

Technical information
  • TDR Targets ID: 214353
  • Name: NCI60_037977
  • MW: 452.457 | Formula: C24H24N2O7
  • H donors: 2 H acceptors: 3 LogP: 1.38 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: OCCNCCCn1c2c3cc4OCOc4cc3C(=O)c2c2c(c1=O)cc(c(c2)OC)OC
  • InChi: 1S/C24H24N2O7/c1-30-17-8-13-16(11-18(17)31-2)24(29)26(6-3-4-25-5-7-27)22-14-9-19-20(33-12-32-19)10-15(14)23(28)21(13)22/h8-11,25,27H,3-7,12H2,1-2H3
  • InChiKey: QCSDJDQOJBQTDV-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis cadherin EGF LAG seven pass G type receptor 0.0019 0.0283 0.0283
Schistosoma mansoni hypothetical protein 0.0019 0.0283 0.0283
Brugia malayi hypothetical protein 0.0031 0.0879 0.2768
Plasmodium falciparum ataxin-2 like protein, putative 0.0031 0.0879 1
Echinococcus granulosus diuretic hormone 44 receptor GPRdih2 0.0019 0.0283 0.0283
Echinococcus multilocularis isocitrate dehydrogenase 0.0019 0.0284 0.0284
Loa Loa (eye worm) hypothetical protein 0.006 0.2437 1
Brugia malayi hypothetical protein 0.002 0.0314 0.0147
Loa Loa (eye worm) hypothetical protein 0.0041 0.144 0.5371
Trypanosoma brucei beta lactamase 0.0077 0.3313 1
Plasmodium vivax ataxin-2 like protein, putative 0.0031 0.0879 1
Trypanosoma brucei PAB1-binding protein , putative 0.0031 0.0879 0.1964
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0019 0.0284 0.0284
Loa Loa (eye worm) isocitrate dehydrogenase 0.0019 0.0284 0.0008
Loa Loa (eye worm) pigment dispersing factor receptor c 0.006 0.2437 1
Echinococcus multilocularis GPCR, family 2 0.0019 0.0283 0.0283
Mycobacterium tuberculosis Class a beta-lactamase BlaC 0.0161 0.7677 1
Mycobacterium leprae PROBABLE CONSERVED LIPOPROTEIN LPQF 0.0077 0.3313 0.5
Schistosoma mansoni hypothetical protein 0.0206 1 1
Mycobacterium tuberculosis Probable conserved lipoprotein LpqF 0.0077 0.3313 0.4097
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0019 0.0284 0.0284
Schistosoma mansoni hypothetical protein 0.0019 0.0283 0.0283
Trypanosoma cruzi PAB1-binding protein , putative 0.0031 0.0879 1
Brugia malayi latrophilin 2 splice variant baaae 0.0041 0.144 0.5371
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.006 0.2437 1
Schistosoma mansoni hypothetical protein 0.0041 0.144 0.144
Leishmania major hypothetical protein, conserved 0.0031 0.0879 1
Brugia malayi Isocitrate dehydrogenase 0.0019 0.0284 0.0008
Echinococcus multilocularis diuretic hormone 44 receptor GPRdih2 0.0019 0.0283 0.0283
Plasmodium falciparum ataxin-2 like protein, putative 0.0031 0.0879 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.006 0.2437 1
Echinococcus granulosus GPCR family 2 0.0019 0.0283 0.0283
Mycobacterium ulcerans class a beta-lactamase, BlaC 0.0161 0.7677 1
Brugia malayi isocitrate dehydrogenase 0.0019 0.0284 0.0008
Trypanosoma cruzi PAB1-binding protein , putative 0.0031 0.0879 1
Schistosoma mansoni NADP-specific isocitrate dehydrogenase 0.0019 0.0284 0.0284
Echinococcus multilocularis isocitrate dehydrogenase 2 (NADP+) 0.0019 0.0284 0.0284
Echinococcus granulosus NADP dependent isocitrate dehydrogenase 0.0019 0.0284 0.0284
Loa Loa (eye worm) hypothetical protein 0.0031 0.0879 0.2768
Echinococcus granulosus cadherin EGF LAG seven pass G type receptor 0.0019 0.0283 0.0283
Toxoplasma gondii LsmAD domain-containing protein 0.0031 0.0879 1
Schistosoma mansoni hypothetical protein 0.0019 0.0283 0.0283
Schistosoma mansoni hypothetical protein 0.0206 1 1
Echinococcus multilocularis geminin 0.0206 1 1
Schistosoma mansoni hypothetical protein 0.0019 0.0283 0.0283
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0019 0.0284 0.0284

Activities

Activity type Activity value Assay description Source Reference
Activity (binding) Poisoning activity at topoisomerase 1 (unknown origin) using 3'-[32P]dGTP labelled 117bp oligonucleotide assessed as induction of DNA cleavage at 1 uM incubated for 20 mins by SDS-PAGE analysis ChEMBL. 26890118
Activity (binding) Inhibition of human recombinant Top1-mediated DNA cleavage at 1 uM after 20 mins relative to camptothecin ChEMBL. 20630766
Activity (binding) = 0 Inhibitory activity of compound against human recombinant DNA topoisomerase I mediated DNA cleavage; Greater activity ChEMBL. 11020283
Activity (binding) = 100 % Activity at recombinant Top1 (unknown origin) using 3'-[32P]-labeled double-stranded DNA (117 bp) as substrate assessed as suppression of DNA cleavage at 0.1 to 100 uM incubated for 20 mins by electrophoretic assay relative to 1 uM camptothecin ChEMBL. 26906474
GI50 (functional) = 0.01 uM Antiproliferative activity was determined for 50% growth inhibition against human lung HOP-62 cell line ChEMBL. 11020283
GI50 (functional) = 0.01 uM Antiproliferative activity was determined for 50% growth inhibition against human renal SN12C cell line ChEMBL. 11020283
GI50 (functional) = 0.01 uM Antiproliferative activity was determined for 50% growth inhibition against human lung HOP-62 cell line ChEMBL. 11020283
GI50 (functional) = 0.01 uM Antiproliferative activity was determined for 50% growth inhibition against human renal SN12C cell line ChEMBL. 11020283
GI50 (functional) > 0.01 uM Antiproliferative activity against human SN12C cells ChEMBL. 18630891
GI50 (functional) > 0.01 uM Antiproliferative activity against human DU145 cells ChEMBL. 18630891
GI50 (functional) < 0.01 uM Cytotoxicity against human SN12C cells ChEMBL. 19783447
GI50 (functional) < 0.01 uM Cytotoxicity against human DU145 cells ChEMBL. 19783447
GI50 (functional) < 0.01 uM Cytotoxicity against human SN12C cells ChEMBL. 20630766
GI50 (functional) < 0.01 uM Cytotoxicity against human DU145 cells ChEMBL. 20630766
GI50 (functional) < 0.01 uM Cytotoxicity against human MCF7 cells ChEMBL. 20630766
GI50 (functional) < 0.01 uM Antiproliferative activity against human SN12C cells by SRB assay ChEMBL. 21710981
GI50 (functional) < 0.01 uM Antiproliferative activity against human DU145 cells by SRB assay ChEMBL. 21710981
GI50 (functional) < 0.01 uM Antiproliferative activity against human MCF7 cells by SRB assay ChEMBL. 21710981
GI50 (functional) = 0.01 uM Cytotoxicity against human SN12C cells by MTT assay ChEMBL. 26906474
GI50 (functional) = 0.02 uM Antiproliferative activity was determined for 50% growth inhibition against human Prostate DU-145 cell line ChEMBL. 11020283
GI50 (functional) = 0.02 uM Antiproliferative activity was determined for 50% growth inhibition against human Prostate DU-145 cell line ChEMBL. 11020283
GI50 (functional) = 0.02 uM Antiproliferative activity against human HOP62 cells ChEMBL. 18630891
GI50 (functional) = 0.02 uM Cytotoxicity against human HOP62 cells ChEMBL. 19783447
GI50 (functional) = 0.02 uM Cytotoxicity against human HOP62 cells ChEMBL. 20630766
GI50 (functional) = 0.02 uM Antiproliferative activity against human HOP62 cells by SRB assay ChEMBL. 21710981
GI50 (functional) = 0.02 uM Growth inhibition of human HOP62 cells after 48 hrs by SRB assay ChEMBL. 24800942
GI50 (functional) = 0.03 uM Antiproliferative activity was determined for 50% growth inhibition against human melanoma UACC-62 cell line ChEMBL. 11020283
GI50 (functional) = 0.03 uM Antiproliferative activity was determined for 50% growth inhibition against human melanoma UACC-62 cell line ChEMBL. 11020283
GI50 (functional) = 0.03 uM Antiproliferative activity against human UACC62 cells ChEMBL. 18630891
GI50 (functional) = 0.03 uM Cytotoxicity against human UACC62 cells ChEMBL. 19783447
GI50 (functional) = 0.03 uM Cytotoxicity against human UACC62 cells ChEMBL. 20630766
GI50 (functional) = 0.03 uM Antiproliferative activity against human UACC62 cells by SRB assay ChEMBL. 21710981
GI50 (functional) = 0.04 uM Antiproliferative activity against human SF539 cells ChEMBL. 18630891
GI50 (functional) = 0.04 uM Cytotoxicity against human SF539 cells ChEMBL. 19783447
GI50 (functional) = 0.04 uM Cytotoxicity against human SF539 cells ChEMBL. 20630766
GI50 (functional) = 0.04 uM Antiproliferative activity against human SF539 cells by SRB assay ChEMBL. 21710981
GI50 (functional) = 0.09 uM Antiproliferative activity was determined for 50% growth inhibition against human CNS SF-539 cell line ChEMBL. 11020283
GI50 (functional) = 0.09 uM Antiproliferative activity was determined for 50% growth inhibition against human CNS SF-539 cell line ChEMBL. 11020283
GI50 (functional) = 0.1 uM Antiproliferative activity against human HCT116 cells ChEMBL. 18630891
GI50 (functional) = 0.1 uM Cytotoxicity against human HCT116 cells ChEMBL. 19783447
GI50 (functional) = 0.1 uM Cytotoxicity against human HCT116 cells ChEMBL. 20630766
GI50 (functional) = 0.1 uM Antiproliferative activity against human HCT116 cells by SRB assay ChEMBL. 21710981
GI50 (functional) = 0.15 uM Antiproliferative activity was determined for 50% growth inhibition against human colon HCT-116 cell line ChEMBL. 11020283
GI50 (functional) = 0.15 uM Antiproliferative activity was determined for 50% growth inhibition against human colon HCT-116 cell line ChEMBL. 11020283
GI50 (functional) = 0.5 uM Antiproliferative activity against human OVCAR-3 cells ChEMBL. 18630891
GI50 (functional) = 0.5 uM Cytotoxicity against human OVCAR-3 cells ChEMBL. 19783447
GI50 (functional) = 0.5 uM Cytotoxicity against human OVCAR-3 cells ChEMBL. 20630766
GI50 (functional) = 0.5 uM Antiproliferative activity against human OVCAR3 cells by SRB assay ChEMBL. 21710981
GI50 (functional) = 0.68 uM Antiproliferative activity was determined for 50% growth inhibition against human breast MDA-MB-435 cell line ChEMBL. 11020283
GI50 (functional) = 0.68 uM Antiproliferative activity was determined for 50% growth inhibition against human breast MDA-MB-435 cell line ChEMBL. 11020283
GI50 (functional) = 0.79 uM Antiproliferative activity against human MDA-MB-435 cells ChEMBL. 18630891
GI50 (functional) = 0.79 uM Cytotoxicity against human MDA-MB-435 cells ChEMBL. 19783447
GI50 (functional) = 1.5 uM Antiproliferative activity was determined for 50% growth inhibition against human ovarian OVCAR-3 cell line ChEMBL. 11020283
GI50 (functional) = 1.5 uM Antiproliferative activity was determined for 50% growth inhibition against human ovarian OVCAR-3 cell line ChEMBL. 11020283
Inhibition (binding) Inhibition of human DNA topoisomerase 1 assessed as induction of enzyme-dependent DNA cleavage relative to 1 uM camptothecin ChEMBL. 19783447
Inhibition (binding) Inhibition of recombinant DNA topoisomerase 1 (unknown origin) assessed as inhibition of topoisomerase 1-mediated DNA cleavage at 1 uM after 20 mins by SDS-PAGE analysis ChEMBL. 23987476
Inhibition (binding) > 95 % Inhibition of recombinant human TOP1 mediated DNA cleavage after 20 mins by gel electrophoresis relative to camptothecin ChEMBL. 21710981
MGM (functional) = 0.21 Mean graph midpoint for growth inhibition of all human cancer cell lines ChEMBL. 11020283

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

7 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.